Consistent with the determined mechanism, we observed that CPT1a and KAT2a proteins were highly co-expressed within lung and liver metastases compared to cranial bone and lymph node metastases (Figure 7g, h). The gene discussed is CPT1A; the disease is benign neoplasm.